Navigation Links
Bionovo Announces 2010 Highlights and Year-End Financial Results
Date:3/15/2011

anism of estrogen receptor beta. As a leading pharmaceutical company in the mediation of estrogen receptors, such studies are critical for potential new products for the Company.
  • potential estrogen receptor modulating drugs for treating menopausal conditions. This is, essentially, a potential roadmap for further pipeline candidates in the Bionovo women's health platform.
  • Menerba's effect on neural pathways related to temperature regulation, further strengthening the Company's understanding of the mechanism of action for Menerba.
  • the discovery of distinct classes of genes regulated by estrogen receptor beta, adding even more to Bionovo's demonstrated understanding of the mechanisms of estrogen receptors.
  • A proprietary, innovative method of high throughput LC-MS/MS tandem quantification of multiple bioactive compounds was described, which is essential to the development of Menerba.
  • A fundamental patent was issued for Bezielle™ in the treatment of metastatic breast cancer.
  • In 2010, the Company was active in accessing the capital markets and government grants for needed funding:
  • In December, the Company filed its intent with the SEC to launch a fully committed underwritten public offering. This offering closed in February 2011 for a total of $27.4 million in net proceeds.
  • In November, the Company announced that it had received a Qualifying Therapeutic Discovery Program (QTDP) grant of $489,000 from the federal government for the Menerba and Bezielle programs.
  • In October, the Company announced the closing of a registered direct offering with select investors for net proceeds of $2.5 million. Although not noted at the time, these fundamental investors were integral to the later, larger, underwritten offering that closed in February of 2011.
  • In September, the Company announced that it had received an NIH grant of $174,000 to develop drugs for the treatment of female-specific obesity
    '/>"/>

  • SOURCE Bionovo, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
    2. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
    3. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
    4. Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants
    5. Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors
    6. Bionovo Releases FDA-Approved Clinical Development Plan for Menerba
    7. Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mechanism
    8. Bionovo Announces Third Quarter 2010 Highlights and Financial Results
    9. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010
    10. Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
    11. Bionovo to Raise $3 Million Through Registered Direct Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)... , March 5, 2015 Vermillion, ... solutions company focused on gynecologic disease, announced today ... results before the market open on Wednesday, March ... and webcast at 8:30am Eastern. Conference Call & ... at 8:30am Eastern/5:30am Pacific Domestic: , 800-753-9057International: , ...
    (Date:3/5/2015)... 5, 2015  BioPhotas, Inc., an FDA registered medical ... photo-therapeutic technologies to treat skin, muscle and joint conditions, ... Fi Fund to provide BioPhotas, flagship product, the ... management solutions.  Commenting on the alliance, ... used the Celluma at the Warrior Hope and Care ...
    (Date:3/5/2015)... HAMILTON, N.J. , March 5, 2015 /PRNewswire/ ... laboratory which specializes in high complexity, state-of-the-art, automated ... offering new Human Papillomavirus (HPV) testing which utilizes ... platforms. Each year, approximately 12,000 women ... the United States . Genital Human Papillomaviruses ...
    Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
    ... NEW YORK, Sept. 30 Law firm Clifford Chance, as ... its merger with Wyeth under China,s Anti-Monopoly Law. The clearance ... September 2009. , Competition approval from the Chinese authorities was ... , The EU has already approved the deal; decisions ...
    ... , LAKE FOREST, Ill., Sept. 30 Hospira, Inc. ... medication delivery company, today announced the acquisition of worldwide ... affiliated European manufacturing facility from PLIVA Hrvatska d.o.o. (Zagreb, ... Hospira,s reach and vertical integration in biogenerics. Financial ...
    Cached Medicine Technology:Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 2Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA 2Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA 3
    (Date:3/6/2015)... (PRWEB) March 06, 2015 Califia ... leader in the natural products coffee drinks category, has ... Cleanest Packaged Foods Awards for its Double Espresso ... packaged foods to the test to find the best, ... must “taste absolutely delicious.” , “As a company dedicated ...
    (Date:3/6/2015)... 06, 2015 As the Muscular Dystrophy ... programs, the organization has hired two new Scientific Program ... They will report to Grace Pavlath, Ph.D, who joined ... Scientific Program Director, and together will lead MDA as ... and cures for various types of neuromuscular and motor ...
    (Date:3/6/2015)... March 06, 2015 Further solidifying their ... Medical Doctor Associates announced today that the company has ... winning the Best of Staffing Talent Award five years ... Best of Staffing Talent Diamond winners are proven industry ... to them by the individuals they have helped find ...
    (Date:3/6/2015)... (PRWEB) March 06, 2015 First Choice ... today. The new facility is located at 13351 W. Bowles ... experienced clinical team is ready 24-7 to provide the highest ... Grossman, Facility Medical Director of First Choice Emergency Room Littleton. ... cutting with the South Metro Denver Chamber of Commerce and ...
    (Date:3/6/2015)... March 06, 2015 Utilizing the latest ... rapidly reach their ideal weight has enabled Diet Doc ... to their already impressive collection of fat loss enhancement ... clients special promotions and savings to help people throughout ... This promotion is especially appealing to new clients ...
    Breaking Medicine News(10 mins):Health News:Prevention Magazine Names Califia Farms Winner of 2015 Cleanest Packaged Food Award 2Health News:Prevention Magazine Names Califia Farms Winner of 2015 Cleanest Packaged Food Award 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 2Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 3Health News:Diet Doc Announces Never Before Offered Discounts, Promotions and Savings for New and Existing Clients 4
    ... Publishes Results of Four-Continent Poll Gauging,Catholic Opinion on Hierarchy,s ... in the face of an,AIDS epidemic that costs millions ... ban on condoms. A new multinational poll, however,shows that ... prolife,because it prevents the spread of HIV and AIDS., ...
    ... chemicals,maker Albemarle Corporation (NYSE: ALB ) will ... as DBM, methylene dibromide, or,MDB) by US$0.30/kg for ... contracts allow., (Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO ), ... higher costs, in particular,higher raw material, transport and ...
    ... genetics appear to be key factors, researchers say , , ... -- over and above socio-economic factors -- appear to ... breast cancer, U.S. researchers are reporting. , One new ... cancer patients and their white counterparts, indicating that cancer ...
    ... research study examining whether magnesium sulfate can protect stroke ... of stroke onset is now expanding to include patients ... , "Deferred consent" in research studies is used in ... severe stroke that occur suddenly and render the ...
    ... In keeping with The,Michael J. Fox Foundation,s ... lives of people with Parkinson,s disease, the,Foundation today ... to,the newly created role of Senior Medical Advisor. ... is associate professor of neurology,and psychiatry at the ...
    ... U.S.,Presidential candidate Hillary Clinton today pledged to expand ... year if elected, setting,the goal of ending malaria-related deaths ... campaign said this funding would be in addition to ... and the Global,Fund to Fight AIDS, Tuberculosis, and Malaria, ...
    Cached Medicine News:Health News:New Poll Shows Catholics Around the World Believe Good Catholics Can Use Condoms 2Health News:Albemarle to Raise Prices of Dibromomethane 2Health News:Studies Reveal Why Breast Cancer Hits Black Women Harder 2Health News:Studies Reveal Why Breast Cancer Hits Black Women Harder 3Health News:Stroke study to add patients who cannot give immediate consent 2Health News:Stroke study to add patients who cannot give immediate consent 3Health News:Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation 2Health News:Malaria Community Applauds Clinton's $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments 2Health News:Malaria Community Applauds Clinton's $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments 3
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: